Infectious diseases Flashcards
Name 5 main live attenuated vaccines
BCG
MMR
oral polio
yellow fever
oral typhoid
HIV testing
When is p24 indicated?
What is better in testing asymptomatic individuals with signs of chronic infection?
P24 test
* Present in newly infected individuals during infection and seroconversion
HIV-1/2 Ab/Ag immunoassay
* screening for chronic HIV infection (most sensitive)
HIV RNA
* For neonatal HIV infection, screening blood donors
Malaria treatment
Non-falciparum malaria
Chloroquine sensitive area
* ACT or chloroquine
Chloroquine resistant area
* Artemisin based combination therapy like artemther-lumefantrine
Malaria treatment
Ovale, vivax
Describe the features distinguishing between vivax/ovale & malariae
Give chloroquine after initial treatment to destroy liver hypnozoites and prevent relapse
Features
* general features of malaria: fever, headache, splenomegaly
* Plasmodium vivax/ovale: cyclical fever every 48 hours.
* Plasmodium malariae: cyclical fever every 72 hours, is associated with nephrotic syndrome.
Malaria treatment
When is IV artesunate indicated?
IV artesunate - parasite count >2%
Give ACT for uncomplicated falciparum malaria
>10% parasitaemia - exchange transfusion
Fever in the returning traveller
Three days ago
Muscle ache
Headache
Maculopapular rash
Thrombocytopenia
Dengue fever
Remember break-bone fever
Virus induced bone marrow suppression and liver derangements
Facial flushing
Dengue - management
No drug treatment, just supportive
Botulism - describe features of presentation
Features
* patient usually fully conscious with no sensory disturbance
* flaccid paralysis
* diplopia
* ataxia
* bulbar palsy
Risk factors - eating tinned food, IVDU
Can mimic Guillian barre syndrome
Management of strongyloidosis
Ivermectin
Diarrhoea in traveller
What are the differences between shigella, giardia, campylobacter, entamoeba histolytica
Shigella dysenteriae
* Incubation period 1-3 days
* Bloody diarrhoea
Campylobacter jejuni
* Bloody diarrhoea - incubation period 2-4 days
Giardia lamblia
* Incubation 3-40 days
* Non bloody diarrhoea
Entamoeba histolytica
* Amoebiasis 2-4 weeks incubation
* Entamoeba - months to years
* Bloody diarrhoea
Syphilis investigations
Non-treponemal tests
Not specific for syphilis
* RPR
* VDRL
* Will become negative after treatment, will show repeat infection
Treponemal specific tests
* Qualitative results - reactive vs non-reactive
* Remain positive after the first infection
* TPHEA, TP-EIA
Campylobacter vs Salmonella
Campylobacter
* Bloody diarrhoea
* Barbecues
Salmonella typhi
* Abdo pain
* Constipation
* Vomiting
Antibiotic for cryptosporidiosis
Only for immunocompromised
Nitazoxanide
Management of multibacillary leprosy (>6 lesions)
This man has multibacillary leprosy (>6 lesions) so should have triple therapy with rifampicin, dapsone and clofazimine for 12 months. For paucibacillary leprosy (5 or less lesions) you should give rifampicin and dapsone for 6 months.
CSF analysis
Describe analysis of bacterial, viral, tuberculosis - appearance, glucose, protein, white cells
- Bacterial - cloudy, low glucose, high protein, WCC high in polymorphs
- Viral - clear or cloudy with slightly low glucose, normal prtein, lymphocytes WCC high
- Tuberculosis - slight cloudy with fibrin web, low glucose, high protein with high lymphocytes
What is used to confirm tuberculous?
The Ziehl-Neelsen stain is only 20% sensitive in the detection of tuberculous meningitis and therefore PCR is sometimes used (sensitivity = 75%)
What would be the result for mumps meningitis
*mumps is unusual in being associated with a low glucose level in a proportion of cases. A low glucose may also be seen in herpes encephalitis
evidence of viral features of CSF sample
Which HPV serotypes increase risk of cervical cancer
Human papillomavirus (HPV), particularly serotypes 16,18 and 33, is by far the most important factor in the development of cervical cancer.
HIV management
Antiretroviral therapy
Describe a typical HIV regimen and rationale
Antiretroviral therapy (ART) involves a combination of at least three drugs, typically two nucleoside reverse transcriptase inhibitors (NRTI) and either a protease inhibitor (PI) or a non-nucleoside reverse transcriptase inhibitor (NNRTI). This combination both decreases viral replication but also reduces the risk of viral resistance emerging
HIV management
Describe MOA of entry inhibitors
Give 2 examples
- Prevents HIV from entering immune cells
- CCR5 antagonist - maraviroc
- Fusion inhibitor - enfuvirtide
HIV management
Nucleoside analogue reverse transcriptase inhibitors
MOA
General SE
Give examples
examples:
zidovudine (AZT),
abacavir,
emtricitabine,
didanosine,
lamivudine,
stavudine,
zalcitabine,
tenofovir
general NRTI side-effects: peripheral neuropathy
HIV management
Specific SE for NRTI
Tenofovir
Zidovudine
Didanosine
- Tenofovir - renal impairment and ostesoporosis
- Zidovudine- anaemia, myopathy, black nails
- Didanosine - pancreatitis
Give 2 examples of NNRTI
SE
Non-nucleoside reverse transcriptase inhibitors (NNRTI)
examples: nevirapine, efavirenz
side-effects: P450 enzyme interaction (nevirapine induces), rashes
HIV management
Give 4 examples of protease inhibitors
Give 6 SE
Protease inhibitors (PI)
examples: indinavir, nelfinavir, ritonavir, saquinavir
side-effects: diabetes, hyperlipidaemia, buffalo hump, central obesity, P450 enzyme inhibition
Integrase inhibitors
MOA
Examples
Integrase inhibitors
* block the action of integrase, a viral enzyme that inserts the viral genome into the DNA of the host cell
* examples: raltegravir, elvitegravir, dolutegravir
HHV-5 infection
Also known as…
Treatment of CMV post renal transplant
Human herpes virus 5 (HHV 5), is cytomegalovirus (CMV).
In patients who are post-transplant, CMV infections can occur from reactivation of latent infection, infection via the transplanted organ, or because of a new primary infection.
‘Treatment is with IV ganciclovir, and where there is ganciclovir resistance, foscarnet or cidofovir are alternative options.
Tuberculosis management
Describe initial phase of treatment
Describe the continuation phase of treatment
Initial phase - first 2 months (RIPE)
* Rifampicin
* Isoniazid
* Pyrazinamide
* Ethambutol (the 2006 NICE guidelines now recommend giving a ‘fourth drug’ such as ethambutol routinely - previously this was only added if drug-resistant tuberculosis was suspected)
Continuation phase - next 4 months
* Rifampicin
* Isoniazid
Tuberculosis management
Latent tuberculosis
The treatment for latent tuberculosis is 3 months of isoniazid (with pyridoxine) and rifampicin OR 6 months of isoniazid (with pyridoxine)
Tuberculosis management
Management of meningeal TB
Patients with meningeal tuberculosis are treated for a prolonged period (at least 12 months) with the addition of steroids
Anti-viral agents
Aciclovir
MOA
Indications
SE
Name of drug: Aciclovir
Mechanism of action: Guanosine analog, phosphorylated by thymidine kinase which in turn inhibits the viral DNA polymerase
Indications: HSV, VZV
Adverse effects/toxicity: Crystalline nephropathy
Anti-viral agents
Galcanciclovir
MOA
Indications
SE
Name of drug: Ganciclovir
Mechanism of action: Guanosine analog, phosphorylated by thymidine kinase which in turn inhibits the viral DNA polymerase
Indications: CMV
Adverse effects/toxicity: Myelosuppression/agranulocytosis